You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
The Immunobiology of Cancer Immunosurveillance and Immunoediting
|
|---|---|
| Published in |
Immunity, August 2004
|
| DOI | 10.1016/j.immuni.2004.07.017 |
| Pubmed ID | |
| Authors |
Gavin P. Dunn, Lloyd J. Old, Robert D. Schreiber |
| Abstract |
The last fifteen years have seen a reemergence of interest in cancer immunosurveillance and a broadening of this concept into one termed cancer immunoediting. The latter, supported by strong experimental data derived from murine tumor models and provocative correlative data obtained by studying human cancer, holds that the immune system not only protects the host against development of primary nonviral cancers but also sculpts tumor immunogenicity. Cancer immunoediting is a process consisting of three phases: elimination (i.e., cancer immunosurveillance), equilibrium, and escape. Herein, we summarize the data supporting the existence of each of the three cancer immunoediting phases. The full understanding of the immunobiology of cancer immunosurveillance and immunoediting will hopefully stimulate development of more effective immunotherapeutic approaches to control and/or eliminate human cancers. |
Mendeley readers
The data shown below were compiled from readership statistics for 2,197 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 14 | <1% |
| Germany | 5 | <1% |
| France | 4 | <1% |
| Denmark | 3 | <1% |
| Spain | 3 | <1% |
| United Kingdom | 3 | <1% |
| Netherlands | 2 | <1% |
| Austria | 2 | <1% |
| Switzerland | 2 | <1% |
| Other | 17 | <1% |
| Unknown | 2142 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 391 | 18% |
| Student > Master | 319 | 15% |
| Student > Bachelor | 291 | 13% |
| Researcher | 235 | 11% |
| Student > Doctoral Student | 117 | 5% |
| Other | 302 | 14% |
| Unknown | 542 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 429 | 20% |
| Medicine and Dentistry | 378 | 17% |
| Biochemistry, Genetics and Molecular Biology | 340 | 15% |
| Immunology and Microbiology | 219 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 67 | 3% |
| Other | 178 | 8% |
| Unknown | 586 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2023.
All research outputs
#1,843,396
of 25,837,817 outputs
Outputs from Immunity
#1,404
of 4,864 outputs
Outputs of similar age
#2,232
of 63,219 outputs
Outputs of similar age from Immunity
#1
of 31 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,864 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 63,219 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.